JP2005535630A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535630A5
JP2005535630A5 JP2004516575A JP2004516575A JP2005535630A5 JP 2005535630 A5 JP2005535630 A5 JP 2005535630A5 JP 2004516575 A JP2004516575 A JP 2004516575A JP 2004516575 A JP2004516575 A JP 2004516575A JP 2005535630 A5 JP2005535630 A5 JP 2005535630A5
Authority
JP
Japan
Prior art keywords
substituted
atoms
carbon atoms
disubstituted
monosubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004516575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005535630A (ja
Filing date
Publication date
Priority claimed from DE10229070A external-priority patent/DE10229070A1/de
Application filed filed Critical
Publication of JP2005535630A publication Critical patent/JP2005535630A/ja
Publication of JP2005535630A5 publication Critical patent/JP2005535630A5/ja
Pending legal-status Critical Current

Links

JP2004516575A 2002-06-28 2003-06-05 2−(フェニル)−2H−ピラゾール−3−カルボン酸−N−4−(チオキソ−ヘテロサイクル)−フェニル−アミド誘導体、ならびに対応するイミノ−ヘテロサイクル誘導体、および関連する化合物の、凝固因子Xaおよび/またはVIIaの阻害剤として、血栓症の治療のための使用 Pending JP2005535630A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10229070A DE10229070A1 (de) 2002-06-28 2002-06-28 Phenylderivate 5
PCT/EP2003/005898 WO2004002477A1 (de) 2002-06-28 2003-06-05 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen

Publications (2)

Publication Number Publication Date
JP2005535630A JP2005535630A (ja) 2005-11-24
JP2005535630A5 true JP2005535630A5 (https=) 2006-07-27

Family

ID=29723536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004516575A Pending JP2005535630A (ja) 2002-06-28 2003-06-05 2−(フェニル)−2H−ピラゾール−3−カルボン酸−N−4−(チオキソ−ヘテロサイクル)−フェニル−アミド誘導体、ならびに対応するイミノ−ヘテロサイクル誘導体、および関連する化合物の、凝固因子Xaおよび/またはVIIaの阻害剤として、血栓症の治療のための使用

Country Status (8)

Country Link
US (1) US20050203127A1 (https=)
EP (2) EP1679073A1 (https=)
JP (1) JP2005535630A (https=)
AR (1) AR040472A1 (https=)
AU (1) AU2003238475A1 (https=)
CA (1) CA2491271A1 (https=)
DE (1) DE10229070A1 (https=)
WO (1) WO2004002477A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416384A1 (en) * 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
US20070004736A1 (en) * 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
WO2006047415A2 (en) 2004-10-26 2006-05-04 Janssen Pharmaceutica, N.V. Factor xa compounds
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
DE102005045115A1 (de) * 2005-09-21 2007-04-05 Siemens Ag Verfahren und Vorrichtung zum Betrieb eines Kommunikationsendgeräts
CA2739488A1 (en) 2008-10-15 2010-04-22 Boehringer Ingelheim International Gmbh Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
CA2738929A1 (en) 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102918034B (zh) 2010-03-30 2015-06-03 维颂公司 多取代芳族化合物作为凝血酶的抑制剂
LT2968297T (lt) 2013-03-15 2019-01-10 Verseon Corporation Multipakeistieji aromatiniai junginiai kaip serino proteazės inhibitoriai
ES2791749T3 (es) 2013-03-15 2020-11-05 Verseon Corp Halogenopirazoles como inhibidores de la trombina
ES2670550T3 (es) 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Derivados de quinolina selectivamente sustituidos
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
KR102736869B1 (ko) 2014-03-07 2024-12-02 바이오크리스트파마슈티컬즈,인코포레이티드 인간 혈장 칼리크레인 저해제
CN106687445A (zh) 2014-09-17 2017-05-17 维颂公司 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物
RU2017131562A (ru) 2015-02-27 2019-03-27 Версеон Корпорейшн Замещенные пиразольные соединения как ингибиторы сериновых протеаз

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU730224B2 (en) * 1996-12-23 2001-03-01 Du Pont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
SK174699A3 (en) * 1997-06-19 2000-08-14 Du Pont Pharm Co Inhibitors of factor xa with a neutral p1 specificity group
US5998424A (en) * 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group

Similar Documents

Publication Publication Date Title
JP2005535630A5 (https=)
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
RU2003110960A (ru) Новые ингибиторы дипептидилпептидазы iv и их применение для понижения кровяного давления
KR950005321A (ko) 프로테아제 저해제의 식별방법 및 그의 용도
KR927003520A (ko) 펩티딜(peptidyl) 유도체
TR200200099T2 (tr) Th2 farklılaşma inhibitörleri
CA2389681A1 (en) Npy y5 antagonist
ATE170845T1 (de) Plättchenaggregationsinhibitoren
RU95122558A (ru) Производные гуанидина
JP2006521355A5 (https=)
KR920002596A (ko) 아지비사이클로 유도체
CA2159450A1 (en) 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
KR920014803A (ko) 인돌 유도체
AR031067A1 (es) Un sachet; una tableta y un polvo efervescente de administracion oral para prevenir y tratar disfunciones sexuales y el uso de l-arginina y/o yohimbina y/o una sal farmaceuticamente aceptable de la misma.
KR960705786A (ko) 치환된 5-환 헤테로사이클, 이의 제조방법 및 이의 용도(Substituted 5-ring heterocycles, their preparation and their use)
KR920019787A (ko) 피라졸로피리딘 화합물 및 이의 제조 방법
PL372657A1 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
KR900018006A (ko) 인간 신경 성장인자의 촉진용 페놀 유도체
CL2004001050A1 (es) Compuesto derivado de 3'-[4-oxo-3-{[(ciclopropil o 2,2,2-trifluoroetil)amino]carbonil}-1,8-naftiridin-1(4h)-il]-3-sustituido-1-1'-bifenil-4-il; composicion farmaceutica; y uso en el tratamiento o prevencion de asma, bronquitis cronica, enfermedad pul
WO2024100452A3 (en) Heterocyclic compounds as sting agonists
HUP0203648A2 (hu) Fekély kezelésére alkalmas gyógyászati készítmények
DE602004006379D1 (de) Benzthiazol-3 oxide zur behandlung von proliferativen störungen
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
CO5080752A1 (es) INHIBIDORES DEL FACTOR DE TRANSCRIPCION NF-kB